Relaxin receptors in hepatic stellate cells and cirrhotic liver

Biochemical Pharmacology

Volumn 73, Issue 7, 2007, Pages 1033-1040

  Bennett, Robert G ^a,b   Dalton, Shana R ^a,b   Mahan, Katrina J ^a   Gentry Nielsen, Martha J ^a,c   Hamel, Frederick G ^a,b   Tuma, Dean J ^a,b  

^a VA NEBRASKA WESTERN IOWA HEALTH CARE SYSTEM   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^c CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Fibrosis; InsL3; LGR7; LGR8; Relaxin 3

Indexed keywords

COLLAGEN; CYCLIC AMP; G PROTEIN COUPLED RECEPTOR; INSULIN LIKE PEPTIDE 3; LEUCINE RICH G PROTEIN COUPLED RECEPTOR 7; LEUCINE RICH G PROTEIN COUPLED RECEPTOR 8; PEPTIDE HORMONE; RELAXIN; RELAXIN 3; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ACTIVATION; CELL DIFFERENTIATION; CONTROLLED STUDY; DISEASE COURSE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LIVER CELL; LIVER CIRRHOSIS; LIVER FIBROSIS; LIVER INJURY; LIVER SINUSOID; MALE; MYOFIBROBLAST; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN SECRETION; RAT; RECEPTOR UPREGULATION; STELLATE CELL;

ANIMALS; HEPATOCYTES; HUMANS; LIVER CIRRHOSIS; RATS; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, PEPTIDE;

EID: 33847156731     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcp.2006.12.007     Document Type: Article

References (37)

1. Sherwood O.D. Relaxin's physiological roles and other diverse actions. Endocr Rev 25 (2004) 205-234
2. Bryant-Greenwood G.D., and Schwabe C. Human relaxins: chemistry and biology. Endocr Rev 15 (1994) 5-26
3. Garber S.L., Mirochnik Y., Brecklin C.S., Unemori E.N., Singh A.K., Slobodskoy L., et al. Relaxin decreases renal interstitial fibrosis and slows progression of renal disease. Kidney Int 59 (2001) 876-882
4. Unemori E.N., Bauer E.A., and Amento E.P. Relaxin alone and in conjunction with interferon-gamma decreases collagen synthesis by cultured human scleroderma fibroblasts. J Invest Dermatol 99 (1992) 337-342
5. Unemori E.N., Pickford L.B., Salles A.L., Piercy C.E., Grove B.H., Erikson M.E., et al. Relaxin induces an extracellular matrix-degrading phenotype in human lung fibroblasts in vitro and inhibits lung fibrosis in a murine model in vivo. J Clin Invest 98 (1996) 2739-2745
6. Samuel C.S., Unemori E.N., Mookerjee I., Bathgate R.A., Layfield S.L., Mak J., et al. Relaxin modulates cardiac fibroblast proliferation, differentiation, and collagen production and reverses cardiac fibrosis in vivo. Endocrinology 145 (2004) 4125-4133
7. Samuel C.S., Zhao C., Bathgate R.A., Bond C.P., Burton M.D., Parry L.J., et al. Relaxin deficiency in mice is associated with an age-related progression of pulmonary fibrosis. FASEB J 17 (2003) 121-123
8. Samuel C.S., Zhao C., Bond C.P., Hewitson T.D., Amento E.P., and Summers R.J. Relaxin-1-deficient mice develop an age-related progression of renal fibrosis. Kidney Int 65 (2004) 2054-2064
9. Samuel C.S., Zhao C., Yang Q., Wang H., Tian H., Tregear G.W., et al. The relaxin gene knockout mouse: a model of progressive scleroderma. J Invest Dermatol 125 (2005) 692-699
10. Friedman S.L. Liver fibrosis-from bench to bedside. J Hepatol 38 Suppl. 1 (2003) S38-S53
11. Tsukada S., Parsons C.J., and Rippe R.A. Mechanisms of liver fibrosis. Clin Chim Acta 364 (2006) 33-60
12. Friedman S.L. Stellate cells: a moving target in hepatic fibrogenesis. Hepatology 40 (2004) 1041-1043
13. Murphy F., Arthur M., and Iredale J. Developing strategies for liver fibrosis treatment. Expert Opin Invest Drugs 11 (2002) 1575-1585
14. Bani D., Nistri S., Quattrone S., Bigazzi M., and Bani Sacchi T. The vasorelaxant hormone relaxin induces changes in liver sinusoid microcirculation: a morphologic study in the rat. J Endocrinol 171 (2001) 541-549
15. Du X.-J., Samuel C.S., Gao X.-M., Zhao L., Parry L.J., and Tregear G.W. Increased myocardial collagen and ventricular diastolic dysfunction in relaxin deficient mice: a gender-specific phenotype. Cardiovasc Res 57 (2003) 395-404
16. Bennett R.G., Kharbanda K.K., and Tuma D.J. Inhibition of markers of hepatic stellate cell activation by the hormone relaxin. Biochem Pharmacol 66 (2003) 867-874
17. Williams E.J., Benyon R.C., Trim N., Grove B.H., Arthur M.J., Unemori E.N., et al. Relaxin inhibits effective collagen deposition by cultured hepatic stellate cells and decreases rat liver fibrosis in vivo. Gut 49 (2001) 577-583
18. Hsu S.Y., Nakabayashi K., Nishi S., Kumagai J., Kudo M., Sherwood O.D., et al. Activation of orphan receptors by the hormone relaxin. Science 295 (2002) 671-674
19. Hendriks H.F., Verhoofstad W.A., Brouwer A., de Leeuw A.M., and Knook D.L. Perisinusoidal fat-storing cells are the main Vitamin A storage sites in rat liver. Exp Cell Res 160 (1985) 138-149
20. Gentry-Nielsen M.J., Preheim L.C., Lyman K.N., McDonough K.H., and Potter B.J. Use of rat models to mimic alterations in iron homeostasis during human alcohol abuse and cirrhosis. Alcohol 23 (2001) 71-81
21. Proctor E., and Chatamra K. High yield micronodular cirrhosis in the rat. Gastroenterology 83 (1982) 1183-1190
22. Kumagai J., Hsu S.Y., Matsumi H., Roh J.S., Fu P., Wade J.D., et al. InsL3/Leydig insulin-like peptide activates the LGR8 receptor important in testis descent. J Biol Chem 277 (2002) 31283-31286
23. Sudo S., Kumagai J., Nishi S., Layfield S., Ferraro T., Bathgate R.A., et al. H3 relaxin is a specific ligand for LGR7 and activates the receptor by interacting with both the ectodomain and the exoloop 2. J Biol Chem 278 (2003) 7855-7862
24. Knittel T., Kobold D., Saile B., Grundmann A., Neubauer K., Piscaglia F., et al. Rat liver myofibroblasts and hepatic stellate cells: different cell populations of the fibroblast lineage with fibrogenic potential. Gastroenterology 117 (1999) 1205-1221
25. Scott D.J., Fu P., Shen P.J., Gundlach A.L., Layfield S., Riesewijk A., et al. Characterization of the rat InsL3 receptor. Ann NY Acad Sci 1041 (2005) 13-16
26. Feng S., Bogatcheva N.V., Kamat A.A., Truong A., and Agoulnik A.I. Endocrine effects of relaxin overexpression in mice. Endocrinology 147 (2006) 407-414
27. Liu C., Chen J., Sutton S., Roland B., Kuei C., Farmer N., et al. Identification of Relaxin-3/INSL7 as a ligand for GPCR142. J Biol Chem 278 (2003) 50765-50770
28. Liu C., Eriste E., Sutton S., Chen J., Roland B., Kuei C., et al. Identification of Relaxin-3/INSL7 as an endogenous ligand for the orphan G-protein-coupled receptor GPCR135. J Biol Chem 278 (2003) 50754-50764
29. Houglum K., Lee K.S., and Chojkier M. Proliferation of hepatic stellate cells is inhibited by phosphorylation of CREB on serine 133. J Clin Invest 99 (1997) 1322-1328
30. Kawada N., Kuroki T., Kobayashi K., Inoue M., and Kaneda K. Inhibition of myofibroblastic transformation of cultured rat hepatic stellate cells by methylxanthines and dibutyryl cAMP. Dig Dis Sci 41 (1996) 1022-1029
31. Reinehr R., Fischer R., and Haussinger D. Regulation of endothelin-A receptor sensitivity by cyclic adenosine monophosphate in rat hepatic stellate cells. Hepatology 36 (2002) 861-873
32. Shimizu E., Kobayashi Y., Oki Y., Kawasaki T., Yoshimi T., and Nakamura H. OPC-13013, a cyclic nucleotide phosphodiesterase type III, inhibitor, inhibits cell proliferation and transdifferentiation of cultured rat hepatic stellate cells. Life Sci 64 (1999) 2081-2088
33. Solis-Herruzo J.A., Hernandez I., De la Torre P., Garcia I., Sanchez J.A., Fernandez I., et al. G proteins are involved in the suppression of collagen alpha 1 (I) gene expression in cultured rat hepatic stellate cells. Cell Signal 10 (1998) 173-183
34. Kubota Y., Temelcos C., Bathgate R.A., Smith K.J., Scott D., Zhao C., et al. The role of insulin 3, testosterone Mullerian inhibiting substance and relaxin in rat gubernacular growth. Mol Hum Reprod 8 (2002) 900-905
35. Hsu S.Y., Nakabayashi K., Nishi S., Kumagai J., Kudo M., Bathgate R.A., et al. Relaxin signaling in reproductive tissues. Mol Cell Endocrinol 202 (2003) 165-170
36. Scott D.J., Layfield S., Riesewijk A., Morita H., Tregear G.W., and Bathgate R.A.D. Characterization of the mouse and rat relaxin receptors. Ann NY Acad Sci 1041 (2005) 8-12
37. Boehnert M.U., Hilbig H., and Armbruster F.P. Relaxin as an additional protective substance in preserving and reperfusion solution for liver transplantation, shown in a model of isolated perfused rat liver. Ann NY Acad Sci 1041 (2005) 434-440